Early results presented at a cancer research conference showed tumor shrinkage and slowed disease progression in patients who ...
Revolution Medicines, Inc. (Nasdaq: RVMD), a late-stage clinical oncology company developing targeted therapies for patients ...
MedPage Today on MSN
Early Lung Cancer Data Show Why FDA Approved HER2 Agent in First-Line
Zongertinib in phase I trial showed sustained efficacy in aggressive disease ...
First-line zongertinib showed antitumor activity in treatment-naive patients with advanced or metastatic HER2-mutant ...
Dr Christine Bestvina discusses EGFR treatment shifts, KRAS trial data, and expanding clinical trial access for community oncologists. Lung cancer treatment has undergone a remarkable transformation ...
Leah Phillips, a Kentucky mom of three, said she was initially told her symptoms were due to a cold, allergies or anxiety ...
The 84-year-old Navy veteran, whose real name is Kenny Jary, boasts over 4 million followers across social media platforms ...
Most people think that lung cancer is a disease that only happens to people who smoke. But cardiothoracic and vascular ...
This press release is not intended for US or UK media. Ingelheim, Germany and Ridgefield, Conn. Boehringer Ingelheim today announced that The New England Journal of Medicine (NEJM) published results ...
The American Lung Association in New York is inviting the New York City community to unite as one mighty force for lung ...
The non-small cell lung cancer clinical trial analysis report delivers important insights into ongoing research of 120+ ...
A meta-analysis explored whether interventions such as acupuncture, rehabilitation, and others can improve cough in patients with lung cancer.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results